The WACC of Faron Pharmaceuticals Oy (FARN.L) is 9.5%.
| Range | Selected | |
| Cost of equity | 7.60% - 11.70% | 9.65% |
| Tax rate | -% - -% | -% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.5% - 11.4% | 9.5% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.61 | 0.96 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.60% | 11.70% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 0.04 | 0.04 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.5% | 11.4% |
| Selected WACC | 9.5% | |